UNAM Foundation & Partnerships The UNAM Foundation, established in 1992, is an independent trust that secures philanthropic support, fosters partnerships, and mobilises resources to strengthen UNAMs mission
5 Conclusion In summary, GLP-1RAs have revolutionized obesity and diabetes management, offering potent weight loss and cardiometabolic benefits, but are best used in conjunction with lifestyle interventions, particularly exercise, to optimize health outcomes and sustainability
W., & Jones, D
Key safety observations from TRIUMPH-1 Dysaesthesia: An abnormal sensation of touch tingling, numbness, or an altered feeling of normal sensations was reported at higher rates at 9mg and 12mg than at lower doses or with comparator medications
Practice Growth : Position your practice as a leader in obesity management, attracting a broader patient base